USCAP Unusual But Non-Esoteric Tumors of the Genitourinary Tract From Which You Cannot Hide 2026

Advanced Genitourinary Pathology Review for Difficult Renal, Bladder, Prostate & Testicular Tumors

The USCAP Unusual But Non-Esoteric Tumors of the Genitourinary Tract From Which You Cannot Hide 2026 course delivers an advanced diagnostic review of uncommon but clinically significant genitourinary neoplasms encountered in modern surgical pathology practice. Developed by leading genitourinary pathologists and released by the United States and Canadian Academy of Pathology (USCAP), this focused educational program addresses the increasingly complex diagnostic landscape of renal, bladder, prostate, testicular, and paratesticular pathology.

While most genitourinary pathology training naturally emphasizes common entities such as clear cell renal cell carcinoma, urothelial carcinoma, prostatic acinar adenocarcinoma, and germ cell tumors, real-world practice frequently presents diagnostically challenging lesions that fall outside these dominant categories. These uncommon tumors often generate significant uncertainty due to overlapping morphology, evolving classification systems, molecular heterogeneity, and broad differential diagnoses.

This course is specifically designed to help pathologists recognize these difficult entities, avoid common interpretive pitfalls, and integrate morphologic, immunohistochemical, and molecular findings into practical diagnostic workflows.

Course Details

• 8 Expert Video Lectures
• 18 Downloadable PDF Files
• Original Release Date: February 6, 2026

Why Uncommon Genitourinary Tumors Matter in Daily Practice

One of the more challenging realities in surgical pathology is that uncommon tumors often create disproportionate diagnostic difficulty relative to their frequency.

In genitourinary pathology, unusual lesions may:

• Mimic more common carcinomas
• Demonstrate overlapping immunophenotypes
• Exhibit deceptive spindle cell morphology
• Contain divergent differentiation
• Require molecular correlation for accurate classification
• Carry major prognostic and therapeutic implications

Many practicing pathologists encounter situations where a lesion initially appears routine but reveals unusual histologic features upon closer examination. In these cases, subtle morphologic clues often determine whether a diagnosis remains straightforward or enters a far more complex differential.

The course appropriately focuses not only on recognizing rare entities, but also on understanding how to systematically approach diagnostically ambiguous cases using:

• Histomorphology
• Immunohistochemistry
• Molecular testing
• Clinical correlation
• Awareness of modern WHO classification updates

Renal Tumors Beyond Conventional Clear Cell RCC

The kidney-focused lectures review:

• Non–renal cell carcinoma renal masses
• Recently described RCC subtypes
• Refined renal tumor classifications
• Molecularly defined renal neoplasms
• Unusual morphologic variants

Renal tumor pathology has undergone significant evolution in recent years due to molecular discoveries and expanded classification frameworks. Many tumors previously grouped under broad RCC categories are now recognized as biologically distinct entities with unique prognostic and therapeutic implications.

The sessions explore how subtle architectural and cytologic features can help distinguish:

• Emerging RCC subtypes
• Mimickers of renal epithelial tumors
• Mesenchymal lesions
• Metastatic processes
• Non-neoplastic imitators

Clinical decision-making becomes especially important as targeted therapies increasingly depend on accurate subclassification of renal neoplasia.

Urothelial Carcinoma Variants & Divergent Differentiation

Bladder pathology remains one of the most morphologically diverse areas within GU pathology.

The course reviews:

• Divergent differentiation in urothelial carcinoma
• Variant histologies
• Non-urothelial urinary tract carcinomas
• Spindle cell lesions of the bladder
• Sarcomatoid and poorly differentiated lesions

One recurring challenge in bladder pathology involves determining whether unusual morphology represents:

• True divergent differentiation
• Dedifferentiation
• Collision tumors
• Secondary involvement by non-urothelial malignancies

The lectures appropriately emphasize practical diagnostic strategies for navigating these difficult differentials while avoiding overdiagnosis or under-recognition of aggressive variants.

Spindle Cell Lesions Across the GU Tract

Spindle cell pathology receives focused attention in both bladder and prostate sessions.

Topics include:

• Spindle cell lesions of the bladder
• Prostatic spindle cell neoplasms
• Sarcomatoid lesions
• Reactive mimickers
• Mesenchymal tumors

Spindle cell lesions remain diagnostically difficult because morphology alone is often insufficient for definitive classification.

The course explores how:

• Growth pattern
• Cytologic atypia
• Stromal features
• Immunohistochemistry
• Clinical context

must all be integrated to reach an accurate diagnosis.

Neuroendocrine & Non-Acinar Prostate Tumors

The prostate-focused lectures address:

• Neuroendocrine differentiation
• Non-acinar prostate carcinomas
• Variant acinar adenocarcinoma subtypes
• Rare prostate neoplasms
• Miscellaneous unusual lesions

As prostate cancer therapy evolves, recognition of neuroendocrine differentiation has become increasingly important due to its association with aggressive biology and altered treatment response.

The sessions appropriately highlight how treatment-related tumor evolution and lineage plasticity may complicate morphologic interpretation in advanced prostate cancer specimens.

Testicular & Paratesticular Non-Germ Cell Tumors

Most testicular pathology teaching centers on germ cell neoplasia. However, the course specifically explores:

• Non-germ cell tumors of the testis
• Paratesticular lesions
• Rare stromal tumors
• Mesenchymal neoplasms
• Mimickers of testicular malignancy

These lesions often create substantial diagnostic uncertainty because many pathologists encounter them infrequently during routine practice.

The discussions focus on building practical diagnostic frameworks rather than relying solely on memorization of rare entities.

Morphology, Immunohistochemistry & Molecular Integration

One of the strengths of the course is its balanced emphasis on multimodal diagnostic reasoning.

The lectures repeatedly demonstrate how modern GU pathology increasingly requires integration between:

• Histologic pattern recognition
• Immunophenotypic interpretation
• Molecular classification
• Clinical and radiologic context

Importantly, the course avoids presenting molecular testing as a replacement for morphology. Instead, molecular techniques are framed as complementary tools used selectively to refine difficult diagnoses.

WHO Classification Updates & Modern Diagnostic Criteria

The educational content also reflects the ongoing evolution of GU tumor classification systems.

Topics include:

• Recently refined entities
• New WHO diagnostic criteria
• Emerging molecular subtypes
• Clinically actionable tumor classifications

As modern pathology increasingly shifts toward biologically driven classification systems, pathologists must remain updated on entities that may not have existed in earlier training paradigms.

Educational Value for Practicing Pathologists

This course is particularly valuable because it focuses on lesions that practicing pathologists are genuinely likely to encounter, rather than extremely rare “zebra” diagnoses seen only in tertiary referral archives.

The teaching approach emphasizes:

• Practical differential diagnosis
• Avoidance of common pitfalls
• Pattern-based interpretation
• Clinical relevance
• Diagnostic efficiency

What’s Included

• 8 expert-led GU pathology video lectures
• 18 downloadable PDF files
• Updated WHO classification discussions
• Practical differential diagnosis frameworks
• Morphology and immunohistochemistry integration
• Molecular pathology correlation

Target Audience

This course is ideal for:

• Academic pathologists
• Community surgical pathologists
• Genitourinary pathology specialists
• Pathology fellows
• Pathology residents and trainees
• Urologic pathology consultants

Why This USCAP GU Pathology Course Matters

Modern genitourinary pathology continues evolving through molecular discoveries, refined classification systems, and increasing recognition of uncommon but clinically significant tumor subtypes. Many diagnostically difficult lesions now require integrated interpretation combining morphology, immunohistochemistry, molecular pathology, and clinical correlation.

USCAP Unusual But Non-Esoteric Tumors of the Genitourinary Tract From Which You Cannot Hide 2026 addresses these challenges through a highly practical and case-oriented review of uncommon GU neoplasms that surgical pathologists are likely to encounter throughout their careers. For pathologists seeking greater confidence in difficult renal, bladder, prostate, testicular, and paratesticular diagnoses, this course provides a focused and clinically relevant educational resource grounded in contemporary genitourinary pathology practice.